Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Urology > Testicular tumors > Flashcards

Testicular tumors Flashcards

(55 cards)

Start Studying
1
Q

What are the types of testicular tumors?

A

Germ Cell tumors (90-95%)

  • Seminoma (65%)
  • Yolk sac tumor
  • Embryonal Carcinoma
  • Choriocarcinoma

Stromal tumors (5-10%)

  • Leydig cell tumor
  • Sertoli cell tumor
  • Granulosa cell tumor

Gonadoblastoma (Rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the risk factors for testicular tumors?

A

Congenital

  • Cryptorchidism
  • Gonadal dysgenesis
  • Testicular feminization
  • Kleinfelter’s syndrome

Cancer history

  • IGCN
  • Personal history of testis cancer
  • Family history of testis cancer

General History

  • HIV infection
  • Infertility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is IGCN?

A

Non invasive precursor of germ cell cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What percentage of GCT patients will have IGCN and what percentage of IGCN will progress?

A

5-9% with Germ cell cancer have contralateral IGCN

50% will progress to germ cell cancer in 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Should IGCN be worked up and treated?

A

Unclear if diagnosis or treatment is necessary
Surveillance: regular scrotal ultrasound with testicular exam
Tx: Orchiectomy or radiation have 100% cure rate, chemotherapy has 66% cure rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the pathology of classic seminoma?

A

Pathology: lobulated and pale, fried egg appearance on histology
20% have lymphocytic infiltrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What markers are produced by seminoma?

A

10% produce b-HCG, never secretes AFP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the important features of spermatocytic seminoma?

A

Spermatocytic seminoma

  • Looks like maturing
  • spermatogonia
  • Presents > 50 years old
  • Rarely metastasizes
  • Treat with radical inguinal orchiectomy and surveillance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the pathology of Embryonal Carcinoma?

A

Pathology: grey-white fleshy mass, necrosis, and hemorrhage. Epithelial like cells with papillary projections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the markers of Embryonal carcinoma?

A

Markers: Possibly AFP or b-HCG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the pathology of yolk sac tumor?

A

Pathology: yellow/pale grey, epithelial cells forming cystic spaces, Schiller-Duval bodies, embryoid bodies, hyaline globules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the markers of Yolk sac tumor?

A

Markers: may secrete AFP and b-HCG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the pathology of Choriocarcinoma?

A

Pathology: peripheral grey-white mass, central hemorrhage, syncytiotrophoblasts, cytotrophoblasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the markers for Choriocarcinoma?

A

Tumor markers: always b-HCG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the pathology of Teratoma?

A

Pathology: Cystic with multiple germ layers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the markers for teratoma?

A

Tumor markers: no AFP or b-HCG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the usually routes of metastasis for testicular tumors?

A

Usually through lymphatics, except for Choriocarcinoma and yolk sac which spread hematogenously.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are typical ages of presentation for testicular tumors?

A

Yolk sac:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the important features of Leydig cell tumor?

A

Leydig cell tumor

  • 10% are malignant
  • Pathology: eosinophilic with Reinke crystal
  • Produce testosterone and 17-ketosteroid
  • Presentation: Precocious puberty in children, impotence, low libido, and gynecomastia in adults
  • Treatment: Orchiectomy and surveillance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the important features of Granulosa cell tumor?

A

Granulosa cell tumor

  • Benign tumor
  • 75% found within 1 month of birth
  • May produce estrogen
  • Orchiectomy is curative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the important features of Sertoli cell tumor?

A

Sertoli cell tumor

  • 10% malignant
  • Produce estrogen and progesterone
  • Presentation: Painless mass, possible virilization and gynecomastia
  • Orchiectomy and surveillance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the presentation of a testicular tumor?

A 
Usually a painless testicular mass
Pain (10%)
Hydrocele (5-10%)
Gynecomastia
5% of germ cell tumors
30-50% of sertoli or leydig cell tumors
Back pain (retroperitoneal metastases)
1-3% are bilateral (often lymphoma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the workup for a testicular mass/tumor?

Study These Flashcards
A
  1. History
  2. Physical exam
    - Genitals
    - Lymph nodes
    - Abdomen
    - Neurological
    - Breast (gynecomastia)
  3. Ultrasound
    Look for hypoechoic intratesticular mass
  4. Serum tumor markers
    AFP (half-life 7 days)
    Quantitative beta-HCG (half life 3 days) (beware hypogonadism)
    LDH (half life 4 days)
  5. Labs: (LFTs, BMP, CBC)
  6. Imaging
    CXR
    CT abdomen and pelvis: Sn 70%
  7. radical Inguinal Orchiectomy
24
Q

What is the Tumor staging system?

Study These Flashcards
A

T1: does not extend into the tunica vaginalis or spermatic cord, no LVI
T2: LVI or extension into the tunica vaginalis
T3: extension into spermatic cord
T4: invasion of the scrotum

25
What is the nodal staging system
N1: nodal mass 5 cm
26
What is the metastasis staging system?
M0: no metastases M1a: non regional nodal or pulmonary metastases M1b: Non pulmonary and non nodal distant metastases
27
What is the serum staging system?
S1: LDH 10, b-HCG > 50,000, AFP > 10,000
28
What is the overall staging system?
Stage I: T1-T4, N0, M0 IA: T1 IB: T2-4 IS: T1-4, S1-3 Stage II: T1-4, N1-3, M0 IIA: T1-4, N1, S0-1 IIB: T1-4, N2, S0-1 IIC: T1-4, N3, S0-1 Stage III: T1-4, N0-3, M1, S0-3 Caveat: T1-4, N1-3, M0, S2-3
29
How are Stage IIC and III risk stratified?
Good risk Seminoma: normal AFP, no extrapulmonary metastases Non seminoma: Testicular or RP primary, no extra-pulmonary mets, S0-1 Intermediate risk Seminoma: Extra-pulmonary mets, normal AFP Non seminoma: Testicular or RP primary, no extra-pulmonary mets, S2 Poor Risk Non seminoma: Mediastinal primary, extra-pulmonary mets, or S3
30
How do you manage Stage IA or IB Pure seminoma?
Compliant and T1-3 - Surveillance (relapse 15-20%) - Chemotherapy (1-2 cycles carboplatin) (3% relapse) - XRT (20 Gy to RPLN/iliac nodes) (relapse 3%) Non-compliant or T4 - Chemotherapy (1-2 cycles carboplatin) (3% relapse) - XRT (20 Gy to RPLN/iliac nodes) (relapse 3%)
31
How do you manage Stage IIA or IIB Pure seminoma?
Stage IIA or IIB | XRT (30-36 Gy to RPLN and Iliac nodes) (relapse 10%)
32
How do you manage Stage IIC or III pure seminoma?
Chemotherapy: BEP x 3, or EP x 4. Intermediate risk gets BEP x 4 Tumor shrinks 3 cm PET scan Tumor grows or markers elevate then salvage therapy
33
What is the likely composition of residual mass after treating Pure seminoma?
Residual masses Malignancy 10-20% Necrosis or fibrosis 80-90% Teratoma (rare)
34
How do you manage stage IA or IB Non-seminomas?
Compliant and T1 - Surveillance (relapse 15-20%) - RPLND (unilateral vs bilateral template) Non-compliant or T2-4 - RPLND - Chemotherapy (BEP x 2)
35
How do you manage stage IIA or IIB Non-seminoma?
S0 - RPLND - Chemotherapy (BEP x 3 or EP x 4) S1 -Chemotherapy BEP x 3 or EP x 4
36
How do you treat stage IIC or III non-seminoma?
Good risk -BEP x 3 or EP x 4 Intermediate risk, Poor risk -BEP x 4
37
How are IIC and III non-seminoma patients managed post chemotherapy?
Residual mass 1 cm but shrunken with normal markers then resect residual Tumor grows or markers elevated then salvage therapy
38
What are the possible causes of residual mass after treatment of IIC or III non seminoma?
Malignancy 10-20% Teratoma 30-40% Necrosis/fibrosis 40-50%
39
How should patients be managed after RPLND for non-seminoma?
If N0 then surveillance If N1-2 And Compliant then surveillance or (EP x 2 or BEP x 2) If N1-2 and Non-compliant then EP x 2 or BEP x 2 If N3 then EP x 4 or BEP x 3
40
What are the benefits of surveillance for seminoma?
Occult malignancy in
41
What are the risks associated with surveillance for seminoma?
15-20% relapse rate over 5 years 32% relapse rate if tumor > 4 cm and rete testis invasion Increased psychological stress Relapse most common in first 2 years (mean time to relapse 7 months)
42
What are the risks associated with XRT for seminoma?
Doubles risk of death from cardiac disease Doubles risk of non germ cell cancer 3-5% relapse rate Acute: N/V, fatigue, bone marrow suppression Late: Peptic ulcer, gastritis, secondary malignancy, CV disease
43
What are the benefits of XRT for seminoma?
Treats metastases in retroperitoneal nodes 99% Cancer specific survival
44
What are the benefits of Chemotherapy for Seminoma?
Treats occult metastases even outside retroperitoneum Lower mortality than XRT 99% Cancer specific survival
45
What are the risks associated with chemotherapy for seminoma?
Myelosuppression, N/V, fatigue, Infertility 4-6% relapse rate at 5 years (1 cycle) 2% for (2 cycles) Drug specific adverse effects
46
What are the adverse effects associated with Carboplatin, Bleomycin, Etoposide, and Cisplatin?
Carboplatin: Myelosuppression, N/V, neuropathy Bleomycin: Pneumonitis, pulmonary fibrosis Etoposide: Myelosuppression, mucositis, N/V, alopecia, leukemia Cisplatin: Nephrotoxicity, Neurotoxicity, Ototoxicity, N/V
47
What are the benefits of surveillance for non seminoma?
70% of N0 tumors will have no nodal metastases
48
What are the risks associated with surveillance for non seminoma?
Higher recurrence rate 25% Psychological stress LVI, >T1, 50% embryonal cell, 70% proliferation rate, absence of yolk sac tumor, all increase risk of recurrence Relapse 15-20% when LVI absent, 50% when LVI present
49
What are the benefits of RPLND for non seminoma?
More accurate staging Nodal mets are treated Less intense follow up 98% cancer specific survival
50
What are the risks associated with RPLND for non-seminoma?
0.3% mortality rate Ejaculatory dysfunction 1-30% (use nerve sparing), Bowel obstruction (1-3%), Chylous ascites (2%), renal vascular injury (3%), 10% relapse (usually outside retroperitoneum)
51
What are the benefits of Chemotherapy for non seminoma?
BEP x 2 Less intense follow up Lower relapse 98% cancer specific survival
52
What are the risks associated with chemotherapy for non seminoma?
Does not treat teratoma Infertility, secondary malignancy, Cardiovascular disease Relapse rate
53
What is the prognosis for stage I seminoma and non seminoma?
Seminoma: > 98% 5 year survival Non-Seminoma: >98% 5 year survival
54
What is the prognosis for Stage IIA and IIB seminoma and non seminoma?
Seminoma: > 95% survival Non-Seminoma: > 95% survival
55
What is the risk for stage IIc and III seminoma and non seminoma?
Good risk Seminoma: 86% survival Good risk Non-seminoma: 94% survival Intermediate risk Seminoma: 72% survival Intermediate risk Non-seminoma: 83% survival High risk Non-seminoma: 71% survival

Urology (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions